Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 41-50 of 90 (Search time: 0.002 seconds).
previous
1
...
2
3
4
5
6
7
8
...
9
next
Item hits:
Preview
Issue Date
Title
Author(s)
2010
Practical considerations for monitoring patients with chronic myeloid leukemia
Branford, S.
;
Hughes, T.
2003
Molecular monitoring of chronic myeloid leukemia
Hughes, T.
;
Branford, S.
2003
Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors
Dewar, A.
;
Domaschenz, R.
;
Doherty, K.
;
Hughes, T.
;
Lyons, A.
2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
O'Brien, S.
;
Guilhot, F.
;
Larson, R.
;
Gathmann, I.
;
Baccarani, M.
;
Cervantes, F.
;
Cornelissen, J.
;
Fischer, T.
;
Hochhaus, A.
;
Hughes, T.
;
Lechner, K.
;
Nielsen, J.
;
Rousselot, P.
;
Reiffers, J.
;
Saglio, G.
;
Shepherd, J.
;
Simonsson, B.
;
Gratwohl, A.
;
Goldman, J.
;
Kantarjian, H.
;
et al.
2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
Hughes, T.
;
Kaeda, J.
;
Branford, S.
;
Rudzki, Z.
;
Hochhaus, A.
;
Hensley, M.
;
Gathmann, I.
;
Bolton, A.
;
van Hoomissen, I.
;
Goldman, J.
;
Radich, J.
2008
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C.
;
Miller, C.
;
Radtke, I.
;
Philips, L.
;
Dalton, J.
;
Ma, J.
;
White, D.
;
Hughes, T.
;
Le Beau, M.
;
Pui, C.
;
Relling, M.
;
Shurtleff, S.
;
Downing, J.
2001
Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases
Hui, C.
;
Bardy, P.
;
Hughes, T.
;
Horvath, N.
;
To, L.
2002
Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene
Branford, S.
;
Hughes, T.
;
Rudzki, Z.
2009
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy
Hughes, T.
;
Hochhaus, A.
2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR
Hui, C.
;
Goh, K.
;
White, D.
;
Branford, S.
;
Grigg, A.
;
Seymour, J.
;
Kwan, Y.
;
Walsh, S.
;
Hoyt, R.
;
Trickett, A.
;
Rudzki, Z.
;
Ma, D.
;
To, L.
;
Hughes, T.
Discover
Author
32
White, D.
24
Branford, S.
23
Hochhaus, A.
13
Radich, J.
12
Kantarjian, H.
12
Saglio, G.
11
Cortes, J.
11
Larson, R.
11
Saunders, V.
10
Kim, D.
.
next >
Subject
60
Leukemia, Myelogenous, Chronic, B...
59
Pyrimidines
52
Imatinib Mesylate
51
Piperazines
50
Benzamides
39
Antineoplastic Agents
36
Fusion Proteins, bcr-abl
34
Protein Kinase Inhibitors
31
Male
29
Female
.
next >
Date issued
1
2020 - 2022
45
2010 - 2019
40
2000 - 2009
4
1995 - 1999